Last Update 01 Jun 26
Fair value Decreased 9.97%ENVX: Silicon Anode And Defense Demand Will Drive Future Battery Adoption
Analysts have adjusted the Enovix fair value estimate from $14.55 to $13.10 as they recalibrated expectations around revenue timing, profitability, and higher P/E multiples, following mixed shifts in price targets and ongoing commentary on smartphone, drone, and defense opportunities.
Analyst Commentary
Recent Street research around Enovix reflects a mix of optimism about the company’s technology and end market opportunities, alongside caution around execution, timelines, and profitability. Target prices range from single digits to the low twenties, which highlights different views on how quickly the company can turn its battery roadmap into scaled revenue.
Bullish Takeaways
- Bullish analysts point to Q1 and Q2 results and guidance as supportive of the current business plan. They note that recent quarters met or slightly exceeded expectations set by the company.
- Several reports highlight progress in smartphone qualification, including alternative testing methodologies and the removal of testing barriers. Bullish analysts view this as helpful for eventual smartphone revenue contribution.
- Analysts with more optimistic price targets cite Enovix’s high energy density lithium ion technology and 100% silicon anode approach as a potential foundation for next generation batteries across smartphones, consumer electronics, drones, and defense. They see this as supportive of a larger addressable market.
- Some bullish analysts acknowledge current manufacturing and margin headwinds but still assign higher P/E multiples. They argue that the company’s positioning in smartphone, drone, and military use cases could justify premium valuation if execution improves.
Bearish Takeaways
- Bearish analysts emphasize that Enovix has lagged in meeting customer performance requirements and manufacturing yields. They see this as a key risk to both execution and the timing of any scale up in revenue.
- Multiple reports explicitly extend revenue timelines, with one pushing out expected revenue inflection by about five quarters. This feeds into lower near term estimates and contributes to reduced price targets.
- There is concern that long smartphone qualification periods, early stage manufacturing hurdles, and expectations for negative margins and cash flow over the coming years limit near term earnings visibility. This makes valuation more sensitive to delays.
- While some analysts acknowledge progress in drones and military opportunities, more cautious views argue that the shift in mix and a slower than previously anticipated ramp in broader consumer applications may justify more conservative price targets and assumptions around growth pacing.
What's in the News
- Q1 2026 revenue of US$7.6 million, about 9% above estimates and 49% year over year growth, primarily tied to defense and industrial shipments. Source: company earnings reports summarized in recent news coverage.
- Q1 2026 loss of US$0.14 per share, slightly better than the consensus loss of US$0.15, with a reported gross margin of 19.2%. Source: recent earnings coverage.
- Stock fell more than 11% after Q1 results as investors reacted to delays in smartphone battery qualification and Q2 guidance calling for an adjusted loss between US$0.17 and US$0.13 per share and revenue of US$8 million to US$9 million. Source: recent news reports.
- Enovix issued revenue guidance of US$8 million to US$9 million for the second quarter of 2026. Source: company guidance disclosures.
- Launch of the MX-1 platform, a silicon enhanced battery line for rugged, rapid discharge applications, including the MX1-B01 drone cell with 360 Wh/kg energy density, manufactured in South Korea and building on an existing graphite anode architecture used with South Korean defense contractors. Source: company product announcement.
Valuation Changes
- Fair Value: revised from $14.55 to $13.10, a modest reduction that reflects updated assumptions.
- Discount Rate: adjusted slightly from 11.00% to 10.84%, indicating a small change in the required return used in the model.
- Revenue Growth: updated from 138.62% to 157.61%, pointing to higher modeled top line expansion over the forecast period.
- Net Profit Margin: moved from 11.59% to 6.27%, reflecting a more conservative view on long term profitability.
- Future P/E: increased from 102.87x to 126.09x, implying a higher valuation multiple being applied to projected earnings.
Key Takeaways
- Expansion into defense and smart eyewear markets offers promising revenue growth opportunities, driven by compliance and high-margin premium pricing strategies.
- Upcoming high-volume production and next-gen battery advancements signal potential revenue and earnings growth aligned with 2025 smartphone and AR/VR launches.
- Dependence on smartphone market success and high-capital manufacturing investments could strain finances and pose risks if demand or production efficiency falters.
Catalysts
About Enovix- Designs, develops, and manufactures lithium-ion battery cells in the United States and internationally.
- Completion of the site acceptance testing for the high-volume manufacturing line in Malaysia is set to boost production capacity and support significant revenue growth with a focus on readiness for smartphone mass production in the fourth quarter of 2025.
- Successful shipment of early engineering smartphone battery samples and positive safety test results indicate future revenue increase potential, pending successful customer qualification for anticipated commercial smartphone launches in 2025.
- Expansion into the defense industry presents a near-term revenue growth catalyst, driven by increased demand for conventional graphite battery products and compliance with allied country supply chain requirements.
- Development and anticipated shipments of custom battery cells for smart eyewear devices and AR/VR markets starting mid-2025 create potential for higher margins due to premium pricing in these high-energy density applications.
- Ongoing advancements in next-generation battery models (EX-2M and EX-3M) and positive customer feedback on energy density performance suggest future earnings growth as these innovations meet evolving customer requirements and could enhance ASPs.
Enovix Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Enovix's revenue will grow by 157.6% annually over the next 3 years.
- Analysts assume that profit margins will increase from -499.6% today to 6.3% in 3 years time.
- Analysts expect earnings to reach $36.8 million (and earnings per share of $0.15) by about June 2029, up from -$171.5 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 126.4x on those 2029 earnings, up from -9.9x today. This future PE is greater than the current PE for the US Electrical industry at 40.1x.
- Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 10.84%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Dependence on successful customer qualification and high-volume production for smartphones in late 2025 could pose risks if delays occur, potentially impacting revenue forecasts.
- High-capital expenditures required for ramping manufacturing lines could strain cash flow if customer demand does not materialize as anticipated.
- Non-GAAP EBITDA and EPS losses forecasted for Q1 2025 suggest continued financial strain, indicating potential challenges in achieving profitability.
- Competitive pressures from incumbent graphite battery technologies may constrain pricing power and market share gains, affecting future earnings growth.
- Uncertainties in scaling production and manufacturing efficiency can lead to delays or increased costs, adversely impacting net margins.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $13.1 for Enovix based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $6.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $586.8 million, earnings will come to $36.8 million, and it would be trading on a PE ratio of 126.4x, assuming you use a discount rate of 10.8%.
- Given the current share price of $7.98, the analyst price target of $13.1 is 39.1% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Enovix?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.